Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

India’s food safety regulators have stepped up scrutiny on multiple fronts this week. The Food Safety and Standards Authority of India (FSSAI) has tightening packaging rules for pan masala and Maharashtra’s Food and Drug Administration (FDA) taking action against retail outlets over alleged hygiene violations.

From what goes into packaged products to how food is stored and handled before it reaches consumers, these developments come at a time when food safety in India is under tight scrutiny.

FSSAI Bans Plastic And Aluminium Foil In Pan Masala Packaging

Under the new Food Safety and Standards (Packaging) Amendment Regulations, 2026, notified on August 10, pan masala packaging can no longer use plastic-based materials, plastic laminates, aluminium foil or metallised layers.

Pan masala can now be packaged in materials made of paper, paperboard, cellulose and other naturally derived materials, provided they are completely free from plastic and synthetic polymers. Tin and glass containers are also allowed.

The decision follows an earlier draft notification issued by FSSAI in April, which proposed adding specific packaging materials for pan masala to the food packaging regulations.

Also read: Why FSSAI Seized 18,000 Boxes Of Diageo Whisky, Vodka Bottles

Why FSSAI Is Targeting Pan Masala's Packaging?

Pan masala sachets have traditionally relied heavily on plastic and foil materials as they are lightweight, inexpensive and the contents are shielded from moisture.

However, such multilayer plastic packaging is difficult to recycle and contributes to persistent plastic waste. The new rules push manufacturers towards packaging made of paper and other naturally derived materials that won't harm the environment.

This does not mean that pan masala itself safer to consume. Pan masala, particularly those containing tobacco or areca nut, continues to be harmful. The regulation is primarily about packaging standards and waste.

Also read: From Liquor to Dabur to VKC Nuts, FSSAI Crackdown Puts Food Safety in Focus: Why It Matters

Maharashtra FDA Cracks Down On Retail Food Safety

On the other hand, Maharashtra FDA suspended the food license of a Blinkit facility in Malad West after it reportedly found cockroach infestation, improper storage and other hygiene violations that posed health safety dangers.

Officials also flagged expired and damaged products, inadequate pest control, poor waste management and improper food storage practices. The license was suspended under Section 32(3) of the Food Safety and Standards Act, 2006.

The incident highlights why storage conditions matter even when food has already passed manufacturing and packaging checks.

Also read: Why Indian Doctors Are Seeking A Ban On Junk Food Ads And Mandatory Warning Labels On Packaging?

Reliance Retail Outlet Under Investigation Over Kaju Katli Complaint

In a separate case in Buldhana, Maharashtra FDA flagged a Reliance Retail outlet after a consumer complaint alleging fungal growth and live larvae in packaged kaju katli.

Officials inspected the outlet on August 8 and seized 54 kaju katli boxes reportedly. The specific batch mentioned in the complaint was no longer available, while another batch of the same product was found in stock.

These incidents underscore an important point: food safety does not end when a product leaves the factory. Packaging, transportation, storage, pest control, temperature management, expiry checks and hygiene at retail outlets all form part of the food-safety chain.

For consumers, checking the product's packaging, expiry dates, storage instructions and signs of contamination remains important. If a packaged food looks, smells or tastes abnormal, it is safer not to consume it and to report it to the food-safety authority.

England is on the verge of becoming one of the first countries in the world to eliminate hepatitis C, after more than 100,000 people received the life-saving pioneering antiviral drugs through the NHS that was rolled out in 2015.

NHS England said the country has already surpassed the World Health Organization’s target of treating at least 80% of patients diagnosed with hepatitis C. The latest numbers show that 81.5% of people diagnosed with chronic hepatitis C between 2015 and 2024 had started treatment.

Professor Frankie Swords, NHS national medical director, said hepatitis C can cause serious complications including liver failure and cancer. She also said that many people may live with the infection for years without knowing they have it.

“That’s why the NHS has worked hard alongside public health teams and charities to find and treat hidden cases,” she said, adding that England is now “leading the world” on the path to eliminate the disease.

“We are making significant progress towards eliminating Hepatitis C as a public health threat,” said Dr Sema Mandal, Deputy Director – Blood Safety, Hepatitis, STIs and HIV Division at UK Health Security Agency (UKHSA).

She added, "The sharp fall in cases since 2015 shows the impact of expanded testing and sustained access to modern curative treatments, and the commitment of health services and community partners across England."

“Treating over 100,000 people in just 10 years is a remarkable achievement and brings England closer than ever to becoming one of the first countries in the world to eliminate this disease as a public health threat,” Mandal said.

UK's Public Health Milestone

Also read: How Chronic Hepatitis Quietly Progresses To Liver Cirrhosis: Why Early Action Can Save Your Liver

Hepatitis C is a blood-borne virus that primarily affects the liver. If the infection becomes chronic and remains untreated, it may lead to cirrhosis, liver failure and liver cancer. But hepatitis C differs from many other chronic viral infections as it can be cured.

Since 2015, England has significantly expanded access to direct-acting antiviral medicines. These tablets are generally taken for just 8 to 12 weeks and can clear the virus in more than 90% of the patients.

An estimated 50,200 adults were living with chronic hepatitis C in England in 2024, down 61.1% from an estimated 129,000 in 2015.

Deaths linked to hepatitis C have also fallen, with NHS England reporting a 36% reduction over the past decade.

Testing Still Remains Crucial

The biggest challenge for the health officials right now is finding people who do not know they are infected with hepatitis C.

The UKHSA estimates that 84.6% of people living with chronic hepatitis C had been diagnosed between 2015 and 2024. While the number is is encouraging, it still below the WHO target of 90%.

Past or current injecting drug use remains the most important risk factor in England. People who received blood transfusions or blood products before widespread hepatitis C screening was introduced are also considered at risk.

Elimination does not mean that hepatitis C will disappear completely. Under WHO criteria, it means reducing transmission, illness and deaths to very low levels while maintaining strong testing, treatment and prevention systems in public health.

The progress is especially significant because the world is currently far away from WHO’s 2030 viral hepatitis elimination targets. WHO estimates that about 47 million people were living with hepatitis C globally in 2024, while around 240,000 people died from hepatitis C-related causes.

Even as the US faces major outbreaks of Cyclospora and Salmonella infections, the Food and Drug Administration (FDA) has finalized safety guidance for operations handling ready-to-eat (RTE) fresh-cut produce.

The guidance incorporates public comments received on the October 2018 draft and replaces the FDA’s 2008 guidance on fresh-cut produce.

“This guidance represents the agency’s current thinking on the issues related to preventing contamination in fresh-cut produce,” the FDA said.

The agency also encouraged the industry to continue advancing food safety practices, including through best-practice documents tailored to specific commodities and processes.

The FDA’s guidance targets manufacturers and processors of fresh-cut produce and recommends measures such as sanitation controls, supplier verification and refrigeration amid ongoing outbreaks of cyclosporiasis and salmonella linked to fresh produce.

What Does the FDA Guidance Include?

The FDA recommendations are not legally binding and are aimed at manufacturers and processors of products such as chopped lettuce, sliced cantaloupe, diced onions, shredded carrots, coleslaw mixes and fruit salads.

Fresh-cut produce can include a single commodity, such as cut lettuce, sliced cantaloupe, diced celery, diced onions and shredded carrots, or combinations of two or more produce items, such as coleslaw mixes and fruit salads.

The FDA has focused on contamination with pathogens including salmonella, cyclospora, E. coli and listeria.

Fresh-cut produce processors should assess whether these pathogens pose potential hazards that require preventive measures, including supply-chain controls, the FDA said.

The recommended measures include:

• Using safe water
• Washing fruits and vegetables with antimicrobial solutions
• Training personnel
• Improving facility design
• Implementing sanitation controls
• Verifying suppliers
• Maintaining appropriate refrigeration

Why Is Fresh-Cut Produce at Risk?

Fresh-cut produce can be particularly susceptible to contamination because pathogens may be introduced at multiple points, including during growing, transportation, manufacturing, commingling with other products or at retail.

The opportunity for contamination can increase at each stage before the food reaches consumers.

Fresh-cut produce also does not undergo a kill step to eliminate pathogens that may be introduced during these processes, and most products are sold ready to eat.

The guidance provides recommendations and examples of how Preventive Controls for Human Food can be implemented to protect fresh-cut RTE produce from biological hazards.

Cyclospora and Salmonella Outbreaks

The guidance comes as the US investigates outbreaks linked to contaminated lettuce and jalapenos that have sickened thousands of people.

The cyclospora outbreak linked to iceberg lettuce from Taylor Farms has spread to 15 states, with Michigan hit the hardest.

“Americans should feel confident in eating fresh produce, including leafy greens at this point,” Diamantas said during an appearance on CNBC. The FDA said it remains confident that iceberg lettuce linked to the cyclospora outbreak had been effectively removed from the market following the July 17 recall.

The US Department of Health and Human Services also said Tuesday on X: “Cyclospora: contained, American food: safe.”

However, the FDA and CDC say the investigation into the cyclospora outbreak remains ongoing.

Separately, Taylor Farms said Monday that it was recalling prepared foods containing jalapenos from retailers in several states because of potential salmonella contamination.